Journal of Lipid Research, Vol 38, 1334-1346, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Characterization of a specific polyclonal antibody against 13- hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL

Y Kato, Y Makino and T Osawa
Department of Applied Biological Sciences, Nagoya University, Japan.

Lipid hydroperoxide may react with protein or amino phospholipid without secondary decomposition. We prepared a polyclonal antibody to lipid hydroperoxide-modified proteins using 13S-hydroperoxy-9Z, 11E- octadecadienoic acid-modified keyhole limpet hemocyanin (13-HPODE-KLH) as immunogen. The antibody recognized 13-HPODE-modified bovine serum albumin (BSA), but not aldehyde-modified proteins, such as malondialdehyde-modified BSA. The antibody also recognized adducts derived from 13-HPODE and 13S-hydroperoxy-9Z, 11E, 15Z-octadecatrienoic acid (13-HPOTRE(alpha)). The oxidized alpha-linolenic acid- and linoleate-protein adducts were recognized by the antibody. Oxidized phospholipid-protein adducts were scarcely recognized by the antibody. However, when ester bonds of phospholipids containing linoleic acid were hydrolyzed by alkaline treatment, the cross-reactivities appeared. The result suggests that a phospholipid hydroperoxide can react with a protein directly or indirectly, and a carboxyl terminal (COOH) of the lipid in an adduct was needed as an epitope. Oxidized LDL (ox-LDL) was prepared by the incubation of LDL with copper ion or 2,2'-azobis(2- amidinopropane)dihydrochloride (AAPH), and the formation of lipid hydroperoxide-modified apolipoprotein was confirmed using the antibody. A slight immunoreactivity was observed in ox-LDL without alkaline treatment. When the ox-LDL was treated with alkali to hydrolyze the ester bonds of the lipid, enhanced antigenicity appeared with time- dependency. The results suggest that lipid hydroperoxide-modified apolipoprotein was formed during the oxidation of LDL.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Kawai, H. Fujii, M. Okada, Y. Tsuchie, K. Uchida, and T. Osawa Formation of N{epsilon}-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification J. Lipid Res., July 1, 2006; 47(7): 1386 - 1398. [Abstract] [Full Text] [PDF]

				Y. Kawai, Y. Kato, H. Fujii, Y. Makino, Y. Mori, M. Naito, and T. Osawa Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein J. Lipid Res., June 1, 2003; 44(6): 1124 - 1131. [Abstract] [Full Text] [PDF]

				Y. Kawai, Y. Kato, D. Nakae, O. Kusuoka, Y. Konishi, K. Uchida, and T. Osawa Immunohistochemical detection of a substituted 1,N2-ethenodeoxyguanosine adduct by {omega}-6 polyunsaturated fatty acid hydroperoxides in the liver of rats fed a choline-deficient, L-amino acid-defined diet Carcinogenesis, March 1, 2002; 23(3): 485 - 489. [Abstract] [Full Text] [PDF]

				S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]

				Y. Kato, Y. Mori, Y. Makino, Y. Morimitsu, S. Hiroi, T. Ishikawa, and T. Osawa Formation of Nepsilon -(Hexanonyl)lysine in Protein Exposed to Lipid Hydroperoxide. A PLAUSIBLE MARKER FOR LIPID HYDROPEROXIDE-DERIVED PROTEIN MODIFICATION J. Biol. Chem., July 16, 1999; 274(29): 20406 - 20414. [Abstract] [Full Text] [PDF]

				J. M. Onorato, A. J. Jenkins, S. R. Thorpe, and J. W. Baynes Pyridoxamine, an Inhibitor of Advanced Glycation Reactions, Also Inhibits Advanced Lipoxidation Reactions. MECHANISM OF ACTION OF PYRIDOXAMINE J. Biol. Chem., July 7, 2000; 275(28): 21177 - 21184. [Abstract] [Full Text] [PDF]